Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine
Mark R. Schleiss
,
Nigel Bourne
, Greg Stroup
, Fernando J. Bravo
, Nancy J. Jensen
, David I. Bernstein
Research output
:
Contribution to journal
›
Article
›
peer-review
100
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Guinea pig
100%
Cytomegalovirus Infection
100%
Recombinant Glycoprotein
100%
Congenital Cytomegalovirus Disease
100%
Glycoprotein B
100%
Human Cytomegalovirus
25%
Alum
16%
Pupal Mortality
16%
Freund's Adjuvant
16%
Freund
16%
Public Health Risk
8%
Vaccination
8%
Subunit Vaccine
8%
High Titer
8%
Enzyme-linked Immunosorbent Assay (ELISA)
8%
Low Dose Rate
8%
Neutralizing Antibodies
8%
Reduced Rate
8%
Congenital Infection
8%
3rd Trimester
8%
Pregnant Dams
8%
DNAemia
8%
Immunology and Microbiology
Guinea Pig
100%
Glycoprotein
100%
Cytomegalovirus Infection
100%
Cytomegalovirus
25%
Freund's Adjuvant
16%
Infection
16%
Antibody Response
8%
Subunit Vaccine
8%
Titer
8%
Neutralizing Antibody
8%
Enzyme-Linked Immunosorbent Assay
8%